Ocugen to seek full approval for Covaxin in US via BLA instead of EUA
Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application (BLA) route based on the recommendation of the US drug regulator.
💡 newsR Knowledge: Other News Mentions
COVID-19 vaccine for children likely by September: AIIMS ChiefIn view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programmeBharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
AIIMS to begin second dose trial of Bharat Biotech's Covaxin on children between 2-6 yearsNot just Bharat Biotech's Covaxin but Zydus Cadila's vaccine for children is also currently under trial in India
PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News
Credit: Oneindia Duration: 02:22Published
You Might Like
Related news from verified sources